Eberhard Krausz

1.6k total citations · 1 hit paper
20 papers, 1.3k citations indexed

About

Eberhard Krausz is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Eberhard Krausz has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Genetics. Recurrent topics in Eberhard Krausz's work include RNA Interference and Gene Delivery (8 papers), Cancer-related Molecular Pathways (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Eberhard Krausz is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Cancer-related Molecular Pathways (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Eberhard Krausz collaborates with scholars based in Germany, United Kingdom and Finland. Eberhard Krausz's co-authors include David P. Lane, Michael Hannus, Hannes Grabner, Eugenio Fava, Marino Zerial, Bianca Habermann, Lucas Pelkmans, Sakari Hietanen, Kerstin Korn and Peter M. Fischer and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Eberhard Krausz

20 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis

2005 500 citations Lucas Pelkmans, Eugenio Fava et al. Nature profile →

Peers

Countries citing papers authored by Eberhard Krausz

Since Specialization

Citations

This map shows the geographic impact of Eberhard Krausz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eberhard Krausz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eberhard Krausz more than expected).

Fields of papers citing papers by Eberhard Krausz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eberhard Krausz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eberhard Krausz. The network helps show where Eberhard Krausz may publish in the future.

Co-authorship network of co-authors of Eberhard Krausz

This figure shows the co-authorship network connecting the top 25 collaborators of Eberhard Krausz. A scholar is included among the top collaborators of Eberhard Krausz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eberhard Krausz. Eberhard Krausz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Fluorescent Two-Hybrid Assay to Screen for Protein–Protein Interaction Inhibitors in Live Cells: Targeting the Interaction of p53 with Mdm2 and Mdm4 2014 ·SLAS DISCOVERY ·Larisa Yurlova, (unknown), (unknown), Ian Hickson, Marc Janssen, Denise Morrison, Ian Stansfield, Christopher J. Brown, Farid J. Ghadessy, David P. Lane, Ulrich Rothbauer, Kourosh Zolghadr, Eberhard Krausz	27
2	Translation of a Tumor Microenvironment Mimicking 3D Tumor Growth Co-culture Assay Platform to High-Content Screening 2012 ·SLAS DISCOVERY ·Eberhard Krausz, Ronald De Hoogt, Emmanuel Gustin, Frans W. Cornelissen, Thierry Grand‐Perret, Lut Janssen, (unknown), (unknown), (unknown), Amy Axel, Pieter J. Peeters, Brett M. Hall, Miroslav Cik	52
3	Development of a high-content screening assay to identify compounds interfering with the formation of the hepatitis C virus replication complex 2010 ·Journal of Virological Methods ·Jan Martin Berke, Denis Fenistein, Frederik Pauwels, (unknown), Oliver Lenz, Tse‐I Lin, Eberhard Krausz, Gregory Fanning	8
4	High-content siRNA screening for target identification and validation 2008 ·Expert Opinion on Drug Discovery ·Eberhard Krausz, Kerstin Korn	3
5	High-content siRNA screening 2007 ·Molecular BioSystems ·Eberhard Krausz	30
6	Cell-based high-content screening of small-molecule libraries 2007 ·Current Opinion in Chemical Biology ·Kerstin Korn, Eberhard Krausz	84
7	Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis breakdown → 2005 ·Nature ·Lucas Pelkmans, Eugenio Fava, Hannes Grabner, Michael Hannus, Bianca Habermann, Eberhard Krausz, Marino Zerial	500
8	High-Throughput RNA Interference Strategies for Target Discovery and Validation by Using Synthetic Short Interfering RNAs: Functional Genomics Investigations of Biological Pathways 2005 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Christoph Sachse, Eberhard Krausz, (unknown), Michael Hannus, Andrew Walsh, (unknown), Dmitriy Ovcharenko, David Dorris, Claude Trudel, Birte Sönnichsen, Christophe J. Echeverri	32
9	Chemotherapy Compounds in Cervical Cancer Cells Primed by Reconstitution of p53 Function after Short Interfering RNA-Mediated Degradation of Human Papillomavirus 18 E6 mRNA: Opposite Effect of siRNA in Combination with Different Drugs 2005 ·Molecular Pharmacology ·(unknown), Eberhard Krausz, Hans Helenius, Sakari Hietanen	56
10	Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand. 2002 ·PubMed ·(unknown), Eberhard Krausz, (unknown), Hans Helenius, Sakari Hietanen	54
11	Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53 2001 ·Gene Therapy ·(unknown), (unknown), Eberhard Krausz, David P. Lane, (unknown), A. Mountain, (unknown)	13
12	Cellular Delivery of Impermeable Effector Molecules in the Form of Conjugates with Peptides Capable of Mediating Membrane Translocation 2001 ·Bioconjugate Chemistry ·Peter M. Fischer, Eberhard Krausz, David P. Lane	112
13	Optimization of Nonviral Gene Transfer of Vascular Smooth Muscle Cells in Vitro and in Vivo 2000 ·Molecular Therapy ·Sorin Armeanu, Jaroslav Pelisek, Eberhard Krausz, Alexandra Fuchs, Detlef Groth, (unknown), Oliver Keil, Jacques Quilici, Pierre H. Rolland, Regina Reszka, Sigrid Nikol	67
14	Activation of p53 in cervical carcinoma cells by small molecules 2000 ·Proceedings of the National Academy of Sciences ·Sakari Hietanen, Sonia Laı́n, Eberhard Krausz, Christine Blattner, David P. Lane	190
15	New approaches to cancer therapies 1999 ·The Journal of Pathology ·Robin Fåhræus, Peter M. Fischer, Eberhard Krausz, David P. Lane	19
16	Needle injection catheter delivery of the gene for an antibacterial agent inhibits neointimal formation 1999 ·Gene Therapy ·Sigrid Nikol, Tanya Y. Huehns, Eberhard Krausz, Sorin Armeanu, Markus G. Engelmann, David M. Winder, Brian Salmons, (unknown)	34
17	New approaches to cancer therapies 1999 ·The Journal of Pathology ·Robin Fåhræus, Peter Fischer, Eberhard Krausz, David P. Lane	1
18	Current Biotechnological Approaches to the Prevention of Restenosis 1998 ·BioDrugs ·Sigrid Nikol, Alexander Maier, Eberhard Krausz, (unknown), Tanya Y. Huehns	1
19	A new cat reporter gene vector designed for rapid and efficient cloning of PCR products 1996 ·Gene ·Eberhard Krausz, Jochen Graw	2
20	Expression of Crystallins, Pax6, Filensin, CP49, MIP, and MP20 in lens-derived cell lines. 1996 ·PubMed ·Eberhard Krausz, Robert C. Augusteyn, Roy A. Quinlan, J.R. Reddan, Paul Russell, (unknown), Jochen Graw	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact